rs10794308 (IFITM3): Thyroid Disease Risk Variant

Key takeaways

  • rs10794308 was identified in one of the largest thyroid disease genetic studies to date, covering approximately 2.9 million genomes from 19 biobanks
  • The study found 570 brand-new genetic loci linked to five thyroid conditions including thyroid cancer
  • The ALT allele at this locus is linked to increased IFITM3-AS1 expression in fat, skin, breast, and immune cell tissues
  • The same ALT allele is linked to reduced IFITM3 expression in whole blood, immune cells, and artery tissue
  • Specific effect sizes for this variant and thyroid disease risk are not yet available in reviewed study text

Key takeaways

  • rs10794308 was identified in one of the largest thyroid disease genetic studies to date, covering approximately 2.9 million genomes from 19 global biobanks
  • The study found 570 newly discovered genetic loci linked to five thyroid conditions including thyroid cancer
  • The ALT allele at this locus is linked to increased IFITM3-AS1 expression in fat, skin, breast, and immune cell tissues
  • The same ALT allele is linked to reduced IFITM3 expression in whole blood, immune cells, and artery tissue
  • Specific effect sizes for this variant's association with thyroid disease are not available in the study excerpt reviewed

What the research says A 2026 multi-ancestry genome-wide association meta-analysis (White SL et al., Nature Genetics, 2026; no PMID available) spanning 19 biobanks and approximately 2.9 million participants examined genetic risk for five thyroid conditions: thyroid cancer, benign nodular goiter, Graves' disease, lymphocytic thyroiditis, and primary hypothyroidism. The study identified 313 previously reported and 570 new independent genetic loci, and found genetic correlations between thyroid cancer, benign nodular goiter, and autoimmune thyroid diseases ranging from rg = 0.16 to 0.97. rs10794308, at the IFITM3-AS1 and IFITM3 locus (referred to below as "this locus"), was among the variants identified; specific association statistics for this locus are not detailed in the available excerpt.

Reported associations

  • Thyroid disease (multi-phenotype): This locus was identified in a meta-analysis covering five thyroid phenotypes (thyroid cancer, benign nodular goiter, Graves' disease, lymphocytic thyroiditis, and primary hypothyroidism) in approximately 2.9 million genomes from 19 biobanks; specific per-disease effect sizes for this locus are not reported in the available excerpt (White SL et al., Nature Genetics, 2026)

Evidence quality The underlying study is a large multi-ancestry meta-analysis of approximately 2.9 million genomes from 19 biobanks, providing substantial statistical power for variant discovery. The study identified 570 new loci across five thyroid phenotypes and reported genetic correlations between these conditions (rg = 0.16 to 0.97). However, specific association statistics (odds ratio, p-value, confidence interval) for rs10794308 itself are not present in the available text, and replication status for this specific locus cannot be confirmed from the available evidence. No PMID is currently available for this publication, which limits inline citeability. GTEx eQTL data provide complementary biological context with high statistical significance (p-values from 6.8e-67 to 1.2e-42 across tissues), but eQTL associations reflect potential mechanisms of gene regulation, not direct evidence of disease risk.

Tissue-specific expression effects

  • IFITM3-AS1: The ALT allele is linked to increased expression in subcutaneous adipose tissue, EBV-transformed lymphocytes, sun-exposed lower leg skin, breast mammary tissue, and non-sun-exposed suprapubic skin GTEx Portal
  • IFITM3: The ALT allele is linked to reduced expression in EBV-transformed lymphocytes, whole blood, and tibial artery tissue GTEx Portal

Lifestyle considerations No lifestyle considerations on file for this variant.

Frequently asked questions

What is rs10794308?

rs10794308 is a genetic variant located near the IFITM3-AS1 and IFITM3 genes. It was identified in a 2026 genome-wide association study as one of 570 new loci linked to thyroid diseases including thyroid cancer.

What thyroid conditions is rs10794308 linked to?

The variant was identified in a study examining five thyroid conditions: thyroid cancer, benign nodular goiter, Graves' disease, lymphocytic thyroiditis, and primary hypothyroidism. Specific per-condition effect sizes are not yet available in reviewed text.

What is IFITM3 and why does it appear in thyroid disease research?

IFITM3 is a gene located near rs10794308. The 2026 GWAS identified this locus in the context of five thyroid diseases, and GTEx data show that the ALT allele reduces IFITM3 expression in blood and immune cells.

What do the GTEx expression results for rs10794308 mean?

GTEx data show that people carrying the ALT allele tend to have higher IFITM3-AS1 expression in several tissues and lower IFITM3 expression in blood and immune cells. These are gene-expression associations that hint at a biological mechanism but are not direct measures of disease risk.

How large was the study that identified rs10794308?

The study combined data from 19 biobanks worldwide and analyzed approximately 2.9 million genomes, making it one of the largest multi-ancestry genetic studies of thyroid diseases conducted to date.